(Q30919683)

English

Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Bondareva IB

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Jelliffe RW

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sokolov AV

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Tischenkova IF

4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Journal of Clinical Pharmacy and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

105-120

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

Valproate: an update--the challenge of modern pediatric seizure management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

Sodium valproate: Serial monitoring of EEG and serum levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

Prediction of valproate serum concentrations in adult psychiatric patients using Bayesian model estimations with NPEM2 population pharmacokinetic parameters

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

Detection of carbamazepine-induced changes in valproic acid relative clearance in man by simple pharmacokinetic screening.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

A review of pharmacodynamics and pharmacokinetics in seizure management.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

Valproate population pharmacokinetics in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2003.00538.X

21 January 2018

Identifiers

10.1111/J.1365-2710.2003.00538.X

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30919683&oldid=2143503613"